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Parathyroid-independent change in renal handling of phosphate
in hyperthyroid rats. Patients with hyperthyroidism have a
plasma concentration and a tubular reabsorption of inorganic
phosphate that is higher than that found in normal subjects.
These alterations found in hyperthyroidism have been attributed
to reduced parathyroid activity, which may result from the mod-
erate rise in plasma calcium. In the first study, we observed thai
hyperthyroidism (HT) induced by injecting levothyroxine (T4)
(50 g/l00 g of body wt, i.p., daily) to parathyroidectomized(PTX) rats led to an increased concentration of plasma phos-
phate, whereas hypothyroidism achieved by removing the thy-
roid gland led to a decreased concentration of plasma phosphate.
HT also increased plasma phosphate in PTX and hypophysecto-
mized rats. In the second study, we investigated whether the T4-
induced rise in plasma phosphate was associated with a change
in the renal handling of phosphate. Eight days after performing
PTX, we induced HT by injecting T4 at the above-mentioned
dose for 10 days. During this period, HT-PTX rats either were
pair-fed with euthyroid-PTX counterparts or were fed ad lib but
with the same phosphate intake as that given to the other ani-
mals. Then, the tubular capacity to reabsorb phosphate was as-
sessed by clearance study. The results showed that in PTX rats
HT led to an increase in the capacity to reabsorb phosphate with-
out changing the urinary excretion of cAMP per milliliter of gb-
merular filtrate. The effect of HT on the tubular phosphate trans-
port was related neither to the caloric intake of the animals nor to
the variations in net intestinal phosphorus absorption. It is con-
cluded that thyroxine can influence the renal handling of phos-
phate and, thus, the level of plasma phosphate independent of
parathyroid hormone.
Modification indépendante de l'hormone parathyroIdienne du
comportement renal du phosphate chez les rats hyperthyroIdiens.
Les malades atteints d'hyperthyroIdie ont une concentration
plasmatique et une reabsorption tubulaire de phosphate in-
organique supérieures a celles des sujets normaux. Ces modifi-
cations ont été attribuées a une diminution de l'activité para-
thyroIdienne qui pourrait étre Ia consequence de l'augmentation
modérée du calcium plasmatique qui est observée au cours de
l'hyperthyroIdie. Au cours d'une premiere étude, nous avons
observe que chez des rats parathyroIdectomisés (PTX)
l'hyperthyroidisme (HT) obtenu par l'injection quotidienne de
levothyroxine (T4) (50 g/l00 g de poids corporel) etait accom-
pagné d'une augmentation du phosphate plasmatique alors que
l'hypothyroIdisme obtenu par l'ablation de Ia glande thyroIde
aboutissait a une diminution du phosphate plasmatique.
L'hyperthyroIdisme augmente aussi le phosphate plasmatique
chez des rats a Ia fois PTX et hypophysectomisés. Au cours
d'une deuxième étude nous avons recherché une modification du
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comportement renal du phosphate associée a l'augmentation du
phosphore plasmatique induite par la T4. A partir du huitiême
jour de Ia parathyroidectomie, l'hyperthyroidie a été déterminée
par l'injection de T4, aux mémes doses que ci-dessus, pendant 10
jours. Au cours de cette période les rats HT-PTX ont été nourris
soit de facon appariée avec leurs homologues PTX eu-
thyroldiens, soit ad libitum mais avec le méme apport de phos-
phore que les autres animaux. La capacité tubulaire de réabsorp-
tion de phosphate a été abcs évaluée par une étude de clear-
ance. Les résultats montrent que chez les rats PTX l'hyper-
thyroIdie determine une augmentation de la capacité de
reabsorption de phosphate sans qu'il y ait de modification de
l'excretion urinaire de cAMP rapportée au ml de filtrat gboméru-
laire. L'effet de HT sur le transport tubulaire de phosphate ne
peut &re mis sur le compte ni de l'apport caborique, ni des varia-
tions de l'absorption intestinale de phosphate. La conclusion est
que Ia thyroxine peut influencer Ic comportement renal du phos-
phate et de ce fait Ia concentration plasmatique de phosphate,
indépendamment de I 'hormone parathyroidienne.
Patients with hyperthyroidism usually display an
increase in concentration of plasma inorganic phos-
phate [1—6]. This rise in concentration of plasma
phosphate could be explained, at least in part, by an
increase in tubular reabsorption of phosphate. In-
deed, an augmentation in the maximal tubular ca-
pacity of phosphate reabsorption has been observed
in patients who are thyrotoxic [6, 7]. This renal ef-
fect has been attributed [6, 8-11] to a decreased se-
cretion of parathyroid hormone (PTH), which could
be explained by an increase in serum calcium sec-
ondary to the thyroxine-induced stimulation of bone
resorption [12, 13]. In hyperthyroidism, however, a
decrease in PTH secretion has not been docu-
mented unequivocally [14, 15]. Our initial purpose,
Received for publication March 29, 1978
and in revised form August 23, 1978.
0085-2538/79/0015—0325 $02.00
© 1979 by the International Society of Nephrology
326 Bonrner et a!
therefore, was to investigate whether a change in
thyroidal status would alter plasma inorganic phos-
phate in parathyroidectomized (PTX) rats. After as-
certaining this, we then studied the renal handling
of inorganic phosphate in experimental hyper-
thyroidism induced by administering levothyroxine
to parathyroidectomized rats.
Protocol 1
Methods
Influence of thyroxine on plasma phosphate, cal-
cium, and magnesium in rats with and without
paraihyroid glands. The concentrations of plasma
phosphate, calcium, and magnesium were deter-
mined in hypothyroid, euthyroid, and hyperthyroid
animals, both in the presence (autotransplantation
of parathyroid glands) and in the absence (surgical
parathyroidectomy) of endogenous PTH secretion.
Male Wistar rats, each weighing about 50 g, were
used. Thyroidectomy was performed, with care that
the recurrent laryngeal nerve was not damaged.
Any possible thyroid remnants in thyroidectomized
animals were destroyed by injecting iodine 131 (50
to 100 sCiJ 100 g of body wt) 2 days after the opera-
tion. Control (euthyroid) animals were sham-oper-
ated. Three weeks after the operation, the serum
concentration of thyroxine (T4) was less than 2.0 ng/
100 ml in all the thyroidectomized animals, com-
pared to 7.5 (sEM) 0.4 in control rats. The protein-
bound iodine (PBI) was found to be 2.9 0.2 /Lg/lOO
ml in thyroidectomized rats, compared to 6.5 0.3
pgI100 ml in control animals.
At the time of thyroidectomy (or sham-opera-
tion), the parathyroid glands either were removed
surgically (PTX animals) or were autotransplanted
into the lateral muscles of the neck. Para-
thyroidectomy was considered to be adequate when
plasma calcium concentration fell by more than 0.65
m after a 12-hour fasting period. Two weeks after
surgery, T4 (50 sg!day i.p.) or its solvent vehicle
was given for 14 days. During this period, the food
intake of the animals was controlled strictly. The
diet (Altromin C-bOO) contained, per 100 g of diet:
1.34 g of calcium, 0.93 g of phosphorus, 100 IU of
vitamin D3, and 320 kcal of energy. Two groups of
euthyroid animals were pair-fed with either hypo-
thyroid (TX) or hyperthyroid animals. Seven days
after starting the daily administration of T4, the PBI
concentration had risen above a value of 25 ig/100
of plasma in all animals. At the end of the 14-day
treatment period, and after the animals were fasted
overnight, we obtained blood samples, by punc-
turing the orbital plexus, between 8 A.M. and 9
A.M., for the determination of plasma concentra-
tions of inorganic phosphate, calcium, and magne-
sium. Since no significant difference in the plasma
levels of these electrolytes was found between the
two euthyroid groups, these values are pooled
("Results," Table 1).
Protocol 2
(A) Influence of thyroxine on the renal handling
qf phosphate in parathyroidectomized animals. In
this series of experiments, the tubular capacity to
transport inorganic phosphate was assessed in eu-
thyroid and hyperthyroid PTX rats. Male Wistar
rats, each weighing 170 to 180 g, underwent para-
thyroidectomies as described. Calcium concentra-
tions were determined in plasma sampled 3 days af-
ter surgery. Only animals displaying a plasma cal-
cium concentration lower than 2.0 ifiM were kept in
the study. Eight days after undergoing PTX, the an-
imals were allotted randomly to three groups, and
they underwent one of the following treatments for
10 days. Group 1: Euthyroid (EU) -PTX rats re-
ceived daily i.p. injections of the solvent vehicle of
T4. Group 2: Hyperthyroid (HT)-PTX rats received
daily i.p. injections ofT4 (50 j.g/100 g body wt) and
were pair-fed with the animals of group 1. Group 3:
HT-PTX rats received daily i.p. injections ofT4 (50
g/100 g body wt), were fed ad lib, but were given
Table 1. Influence of thyroid status on plasma concentration of inorganic phosphate, calcium, and magnesium in rats with (+) and
without (—) parathyroid glands
Inorganic phosphate
mM
Calcium
rn
Magnesium
mM
+++ — — —
Hypothyroid 2.68 0.03 3.84 Ø11b 2.45 0.03 1.64 0.05 0.91 0.03 0.81 0.02
Euthyroid 2.95 0.05 4.41 0.12 2.42 0.02 1.61 0.04 0.94 0.03 0.89 0.04
Hyperthyroid 3.04 0.05 4.97 o•09r 2.39 0.03 1.48 0.05 1.02 0.04 0.95 0.04
a All values are means SEM obtained in 12 and 9 animals in the groups with (+) and without (—) parathyroid glands, respectively.
"P < 0.01, compared to the corresponding euthyroid group.
P <0.001, compared to the corresponding euthyroid group.
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the same amount of phosphate as that given to
group 1 (see below).
All animals had free access to distilled water.
Groups 1 and 2 received a diet containing, per 100 g
of diet, 1.1 g of calcium, and 1.2 g of phosphate.
This diet was prepared by the addition of sodium
phosphate and calcium gluconate to a basic diet (Al-
tromin C-1730) containing, per 100 g of diet, 0.2 g of
phosphate and 0.1 g of calcium. The food intake
was controlled within triplets consisting of one ani-
mal of each group. Within each triplet, the HT-PTX
animals (group 2) received as much food as the EU-
PTX controls (group 1) had consumed the night be-
fore. The HT-PTX animals of group 3 could eat
food ad lib; the phosphate content of the diet of
group 3, however, was adjusted so that their phos-
phate intake was similar to that recorded the day
before in group 1. This was achieved by providing
diets containing 0.96, 0.84, or 0.72 g of phosphate
per 100 g of diet. These diets were prepared as men-
tioned above by adding various amounts of sodium
phosphate to the same basic diet (Altromin c-I 730),
The calcium content of these three diets was also
fixed at 1.1 g/lOOgof diet.
After 10 days of pair-feeding and T4 treatment
(that is, 24 hours before the clearance experiments),
we performed subtotal cystectomies on the animals,
while they were under light ether anesthesia, to re-
duce the dead space of the urinary tract. To obviate
any influence of circadian rhythm on phosphate ex-
cretion, we started all experiments at about 8:30
A.M. The clearance measurements in conscious rats
were performed as previously described [16, 17].
For the present study, a first dose (priming) of inulin
(0.4 pCi of (methoxy-3H)-inulin, New England Nu-
clear, with 12.8 mg of unlabeled inulin, Fluka, dis-
solved in 0.15 M sodium chloride) was injected i.v.
in a volume of 0.4 ml. Isotonic solutions containing
5 pCi of (methoxy-3H)-inulin per 100 ml of solution
and 1 g of unlabeled inulin per 100 ml of solution
and increasing amount of phosphate were infused
then at 4 ml/hr. The animals were infused first with
0.15 M sodium chloride for a 90-mm equilibration
period. Then, a first urine-collection period of 30
mm's duration was made, at the end of which a
blood sample was taken from a dorsal hind limb
vein. The rats were then infused with phosphate at
stepwise increasing doses (45-mm equilibrations
followed by 30-mm urine-collection periods): 60
jsmoles, 120 pmoles, and 180 pmoles of phosphate
per hour. Blood samples were taken again immedi-
ately at the end of each urine collection period.
In a second series of experiments, the influence
ofT4 on the renal handling of phosphate was studied
under marked extracellular volume expansion. This
study was made in EU- and HT-PTX rats. The ani-
mals were treated and pair-fed like those presented
above in groups 1 and 2. The clearance experiments
started, as described above, by infusing i.v. a 0.15
M sodium chloride and inulin solution at 4 ml/hr.
After a 90-mm equilibration period, urine was col-
lected for 30 mm. The 0.15 M sodium chloride solu-
tion was then infused at 20 ml/hr until the end of the
experiment. After a second equilibration period of
60 mm's duration, a 15-mm urine collection was
made. Then phosphate was infused at 60, 120, and
180 pmoles/hr. For each i.v. phosphate load, urine
was collected for 15 mm after a 45-mm equilibration
period. At the end of each urine collection, a blood
sample was taken as described above. The degree
of extracellular fluid volume expansion achieved in
this experiment was estimated by weighing the ani-
mals at the beginning and end of the isotonic saline
infusion. The mean (± sEM) increase in body weight
was 21.3 3.8%(N = 6)and 19.5 3.4%(N = 6)in
the EU and HT rats, respectively. In addition in this
series of experiments, the urine samples were col-
lected in chilled test tubes, and aliquots were imme-
diately frozen for later determination of cAMP.
(B) Influence of thyroxine on intestinal phos-
phorus absorption. Since change in the supply and
thus in the intestinal absorption of phosphorus has
been shown to markedly alter the renal handling of
phosphate [18, 19], the influence ofT4 on this vari-
able was assessed. EU- and HT-PTX rats belonging
to groups 1 and 2 were pair-fed and treated as de-
scribed above for 11 days. Then, the animals were
put in individual metabolic cages. T4 treatment and
pair-feeding were continued for another 6-day peri-
od. During the last 72 hours, the food intake was
monitored, and feces and urine samples were col-
lected for phosphorus determination. From these
three measurements, the net intestinal absorption
and the body retention of phosphorus were calcu-
lated.
Analytical methods: Protocol 1. Inorganic phos-
phate concentration was determined in plasma by
the method described by Henry [20], and calcium
and magnesium concentrations were by atomic ab-
sorption spectrophotometry (Perkin Elmer, Type 290
B). Protocol 2. Urinary volume (V) was determined
by weighing. The activity of 3H-inulin in plasma and
urine was measured in a scintillation spectrometer.
Phosphate was determined in diets, plasma, urine,
and feces as phosphomolybdate after reduction
with 10% ascorbic solution [211. Sodium concentra-
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tion in plasma and urine was determined by flame
photometry (EEL, flame photometer, Evans Elec-
troselenica Ltd., Halstead, Essex, England). The
diets and feces were analyzed after incineration of
the samples and dissolution of the ash in 0.1 M hy-
drochloric acid. The osmolality of solutions for in-
fusion was measured with an osmometer (Model
3W, Advanced Instruments Inc., Needham
Heights, Massachusetts, USA). Urinary cAMP was
determined by competitive binding assay with a
commercial kit (cAMP assay kit, The Radio-
chemical Centre, Amersham, England).
Statistical analysis. Significance of difference be-
tween groups was assessed by the two-sided Stu-
dent's t test.
Results
Influence of thyroxine on plasma phosphate. In
the presence of parathyroid glands, plasma phos-
phate (Table 1) was significantly lower in hypothy-
roid (HT) than it was in euthyroid (EU) animals. No
significant difference, however, was found between
HT and EU rats. In the absence of parathyroid
glands, the plasma phosphate level was also signifi-
cantly lower in hypothyroid than it was in EU rats.
Furthermore, in PTX animals, a difference in
plasma phosphate between HT and EU rats could
be observed. As expected, the phosphate concen-
tration was significantly (P < 0.01) higher in PTX
animals than it was in the corresponding groups
with parathyroid glands. The change in phosphate
concentration observed in hypothyroid or HT rats
was not associated with any significant alteration in
plasma calcium or magnesium concentrations
(Table 1).
Influence of thyroxine on the renal handling of
phosphate in parathyroidectomized rats. In this se-
ries of experiments (Table 2), a trend for an increase
in plasma phosphate concentration was noted also
in HT animals. Such an elevation could still be ob-
served 2 hours after the outset of the saline infusion
(period 1), and it persisted when phosphate was de-
livered at 60 and 120 moles/hr. Nevertheless, the
difference achieved statistical significance only
when the HT group pair-fed with respect to food
(HT-pfF) was compared to the EU animals (Table
2). When the largest phosphate load (180 pmoles/hr)
was administered, the difference in plasma phos-
phate between EU and HT rats was cancelled.
During the first three clearance periods, the in-
creased plasma phosphate in HT rats was not asso-
ciated with a commensurate elevation in urinary ex-
cretion of phosphate (U1V) per milliliter of glomer-
ular filtrate (GF). Hence, tubular reabsorption of
phosphate (TRP1) was higher in HT rats even when
factored per milliliter of glomerular filtrate (GF). It
is well established that in intact [22] or PTX [18, 23,
24] rats a stable maximal phosphate transport ca-
pacity (Tm) cannot be observed, since TRP per mil-
liliter of GF decreases during the acute infusion of
phosphate. The same phenomenon is observed also
in this study, not allowing the use of Tm/GF for ex-
pressing the phosphate transport capacity. That T4
actually induced an increase in the tubular capacity
Table 2. Renal handling of inorganic phosphate (Ps) in euthyroid- (EU) and hyperthyroid- (HT) parathyroidectomized (PTX) ratsa
Period
Infused
P, rate
pino/e/hr Grouph tn//mm
FE
%
[P]
tnM
UFV
.unoles/,nlGF
TRP1
.imo1es/min
TRP1
pinoles/mi
UF
1 0 EU
Ht-pfF
HT-pfP
1.87
2.44
2.67
0.12
0.20°
÷ o2ld
4.62 0.53
1.63 0.33°
2.70 0.33°
4.22 0.08
4.99 0.16°
4.52 0.29
0.44 0.08
0.17 0.07°
0.08 005°
6.78 0.44
11.59 085
11.85 1.06°
3.78 0.14
4.81 0.17°
4.44 0.27
2 60 EU
HT-pfF
HT-pfP
1.92
2.72
2.52
0.15
0.15°
0.17°
3.87 0.27
1.87 0.32°
1.63 0.23°
4.66 0.16
5.67 0.12°
5.29 0.12°
0.61 0.06
0.38 0.11
0.18 0•09d
7.90 0.53
14.45 0.93°
12.86 1.06°
4.06 0.20
5.30 0.17°
5.11 0.201
3 120 EU
HT-pfF
HT-pfP
1.80
2.49
2.42
0.10
0.12°
0.15°
4.2! 0.44
2.42 0.28°
2.33 014d
5.09 0.17
5.82 0.11°
5.65 0.2!
1.12 0.07
1.03 0.09
0.79 0.09°
7.09 0.39
11.82 0.54°
11.70 0.85°
3.97 0.21
4.78 0.18°
4.86 0.26°4 180 EU
HT-pfF
HT-pfP
1.93
2.52
2.43
0.21
0.14°
0.13
4.52 0.47
2.35 0.12°
2.54 0.22°
5.63 0.20
5.92 0.13
5.83 0.18
1.75 0.09
1.63 0.05
1.64 0.05
7.36 0.76
10.73 O.54
10.19 0.64c
3.88 0.18
4.29 0.13
4.20 0.21
a All values are means SEM.
b Abbreviations are for tubular reabsorption of phosphate (TRP1), and pair-fed (p0 with EU-PTX rats for food (F) and phosphorus (P).
The daily mean (± sliM) of food intake (g dry weight) measured during the 10 days preceding the clearance study was: in EU, 23.5 0.7;in HT-pfF, 23.4 0.7; in HT-pfP, 29.0 1.6. On the clearance day the body weight (± sEM) was: in EU, 227 4g; in HT-pfF, 201 4g;
in HT-pfP, 206 6g. Number of animals: EU, N = 7; HT-pfF, N = 8; HT-pfP, N = 6.
°P <0.05, compared to EU group.
dP < 0.01, compared to EU group.
ep <0.001, compared to EU group.
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to reabsorb phosphate is illustrated in Fig. 1. In-
deed, up to a plasma phosphate concentration of
about 5.5 mivi, the fractional excretion of phosphate
was always lower in HT than it was in EU rats.
Note that no apparent difference in the renal han-
dling of phosphate could be detected between the
two hyperthyroid groups. This indicates that the T4-
induced change in the tubular capacity to reabsorb
phosphate is not related to a difference in the
amount of ingested calories. As expected [25, 26],
the GFR was markedly increased in both HT groups
as compared to the EU animals (Table 2). The frac-
tional excretion of sodium (FENa) was significantly
reduced in hyperthyroid animals (Table 2). These
differences in GFR and FENa were observed
throughout the experiment.
Influence of thyroxine on the renal handling of
phosphate during extracellular volume expansion.
The results of FENa presented above suggested that
the T4-induced change in the renal handling of phos-
phate was secondary to alteration in extracellular
volume (ECV) and tubular reabsorption of sodium.
To investigate whether a marked increase in ECV
and FENa could cancel the effect of T4 on the renal
handling of phosphate, we studied the tubular re-
sponse to phosphate infusion in rats receiving a so-
lution of isotonic saline at 20 ml instead of 4 mi/hr.
In EU as in HT-PTX rats, increasing the rate of sa-
line infusion decreases plasma phosphate without
significantly changing FE1 (Fig. 2). Such an obser-
Fig. 1. Influence of hyperthyroidism on the renal handling of in-
organic phosphate (Pd) in parathyroidectomized rats. Hyperthy-
roidism was induced by injecting thyroxine (T4) at the dose of 50
g/100 g body wt, i.p., for 10 days. Then fractional excretion of
phosphate (FEP1) was measured at endogenous and increasing
plasma phosphate concentration altered by infusing phosphate at
60, 120, and 180 moles/hr. Values are the means SEM. See
text and Table 2 for further details.
— I I I
3.0 4.0 5.0 6.0
Plasma P1. mm
Fig. 2. Maintenance of the influence of hyperthyroidism on the
renal handling of inorganic phosphate (Pt) of parathyroidecto-
mized rats during acute extracellular volume expansion. Hyper-
thyroidism was induced by injecting thyroxine (T4) at the dose of
50 gIl00 g body wt, i.p., for 10 days. Then the fractional excre-
tion of phosphate (FE) was measured first at endogenous
plasma phosphate concentration when the animals were infused
iv. with 0.15 M sodium chloride solution delivered at4(ALJ) and
20 (A•) mllhr. Under this latter rate of infusion, plasma phos-
phate concentration was raised by infusing phosphate at 60, 120,
and 180 moles/hr. Values are means SEM. See text and Table
3 for further details.
vation is consistent with the large number of obser-
vations 1122, 27-321 indicating that ECV expansion
reduces the tubular capacity to reabsorb phosphate.
This effect of ECV expansion is evident also when
the values of U1V/ml GF in either EU or HT-PTX
animals are compared (Table 3) at similar plasma
phosphate concentrations before (period 1) and dur-
ing marked ECV expansion (period 3). With respect
to the effect of T4, Table 3 shows that the difference
in TRP1/ml GF is not abolished under marked ECV
expansion. Indeed, in these circumstances, FE
remains smaller in HT-PTX than it does in EU-PTX
animals over a wide range of plasma phosphate
(Fig. 2). The difference in FENa between EU- and
HT-PTX rats, however, also was maintained
throughout this experiment, with the exception of
period 2 (Fig. 3, Table 3). As a consequence of the
increased GFR, the diminutions in the FENa and
FEH2O were not associated with concomitant reduc-
tions in their absolute excretion rate in HT animals.
This is illustrated in Fig. 3, where the fractional and
absolute excretion of sodium or water are plotted
against their respective cumulative infused load.
L A Euthyroid
0 • Hyperthyroid, pair-fed
40
30-
20
10.
St
u.j
U- 1*/
St
UJ
U.
Plasma P, mm
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Table 3. Renal handling of inorganic phosphate and urinary cAMP excretion during extracellular volume expansion in euthyroid- (EU)
and hyperthyroid- (HT) parathyroidectomized (PTX) ratsa
Infusion rate
Pe- Fluid
nod rn//hr
P1
iino1e/
hr Group
C1
mi/mm
FE
%
[P1]
mri
U.V
pinole/mi GF
TRP1
pinole/min
TRP1
pinolesimi GF
UCAMPV
pmoles/ml
GF
1 4 0 EU
HT-pfF
1.81 0.12
2.23 0.14
3.81 0.41
2.14 0.30
4.72 0.12
5.38 Q•16b
0.316 0.095
0.218 0.079
7.88 0.23
11.48 0.78c
4.40 0.15
5.17 0.17c
26.2 0.9
22.2 4.1
2 20 0 EU
HT-pfF
1.70 0.18
2.40 018b
7.36 1.05
733 0.66
4.40 0.07
5.05 0•10d
0.211 0.046
0.207 0.056
7.11 0.79
11.59 0.89
4.19 0.08
4.84 Q10d
26.5 4.2
29.2 1.9
3 20 60 EU
HT-pfF
1.58 0.16
2.39 0.12c
16.46 0.50
9.92 0•69d
4.64 0.08
5.42 0.12"
0.559 0.054
0.409 0,054
6.42 0.63
11.95 07Jd
4.08 0.05
5.01 0.16"
20,2 2.8
33.7 4.8'
4 20 120 EU
HT-pfF
1.71 0.20
2.35 0.18"
16.08 0.88
13.38 0.80"
5.32 0.06
5.75 0.10"
1.153 0.068
0.945 0.037"
7.30 0.75
11.33 0.90's
4.17 0.09
4.81 0.09"
100.8 9.0
87.8 8.6
5 20 180 EU
HT-pfF
1.47 0.21
2.12 0.15"
19.06 0.82
13.14 0.23"
5.66 0,08
5.87 0.15
1.975 0.050
1.516 0.047"
5.44 0.81
9.25 0.75'
3.69 0.11
4.35 0.14'
63.0 6.6
66.3 7.2
a See Table 2 for definition of abbreviations. Number of animals were: EU, N = 6; HT-pfF, N 6. On the clearance day the body
weight (± SEM) was: in EU, 190 3 g; in HT-pfF, 164 3 g.
bp <0.05, compared to the EU group.
'P <0.01, compared to the EU group.
"p <0.001. compared to the EU group.
Influence of thyroxine on urinary cAMP. Table 3
also indicates that the effect of T4 on the renal han-
dling of phosphate is not associated with a dif-
ference in the excretion rate of cAMP monitored
per milliliter of glomerular filtrate (GF). Note that in
this experiment UCAMPV/ml GF appears to increase
significantly in both EU and HT rats in response to
phosphate, or isotonic saline infusion, or both.
Influence of thyroxine on intestinal phosphorus
absorption. To determine whether a change in the
renal handling of phosphate could be the result of a
primary alteration in the intestinal absorption, or in
the body retention of phosphorus, or in both, we
made a balance study in a group of HT-PTX rats
pair-fed with EU-PTX counterparts. No significant
difference in net phosphorus intestinal absorption
(ingested phosphate minus fecal phosphate) could
be detected: HT rats, 91 (sEM) 2 mg/day, N = 7;
EU rats, 88 2 mg/day, N = 7. Urinary phosphate
excretion was not significantly altered by T4 admin-
istration: HT rats, 49 4 mg/day; EU rats, 42 3
mg/day. Thus, under these experimental condi-
tions, T4 did not change the overall phosphorus re-
tention: HT rats, 42 2 mg/day; EU rats, 46 2
mg/day.
Discussion
Influence of thyroxine on plasma inorganic phos-
phate. Our study shows that thyroxine (T4) can in-
crease the concentration of plasma phosphate in the
absence of endogenous parathyroid hormone
(PTH). In fact, the rise in plasma phosphate in re-
sponse to T4 administration is even more pro-
nounced in the absence than it is in the presence of
endogenous PTH. In view of these experimental
findings, it appears unlikely that the elevated
plasma phosphate concentrations observed in hy-
.perthyroid patients [1—3, 5, 6, 33] result merely from
a reduction in PTH secretion, which until now usual-
ly has been assumed [6, 8, 11]. Our study also
shows that removal of the thyroid gland leads to a
decrease in plasma phosphate in the para-
thyroidectomized (PTH) animal. This suggests that
thyroid hormones influence plasma phosphate not
only in pharmacologic, but also in physiologic
amount. The hyperphosphatemic effect of T4 is not
associated with any consistent change in the con-
centration of plasma calcium and magnesium. It
does not seem to require the presence of growth
hormone or other pituitary factors. Indeed, in hy-
pophysectomized (HPX) and PTX rats, administra-
tion of T4 (50 pg/day, i.p., for 14 days) also induced
a rise of the phosphatemia: HPX-PTX + T4, 3.71
(± SEM) 0.16 mM, N = 9; HPX-PTX + solvent ve-
hicle 2.67 0.09 mrvi, N = 9; P <0.01. The report-
ed balance study made in pair-fed animals indicates
that neither the net intestinal absorption nor the uri-
nary excretion of phosphate appear to be altered
under the influence of long-term T4 administration.
Therefore, a change in the extrarenal handling of
phosphate does not seem to play any significant role
in the elevation of plasma phosphate. It appears
more likely that the influence ofT4 on plasma phos-
phate of PTX animals is directly related to its action
on the tubular handling of phosphate.
Influence of thyroxine on the renal handling of
inorganic phosphate. Our study demonstrates that
the stimulatory effect of T4 on the tubular capacity
to reabsorb phosphate can be elicited in PTX ani-
mals. This strongly suggests that the increased Tm
(maximal phosphate transport capacity) previously
observed in thyrotoxic patients [6, 7] is a PTH-inde-
pendent process. In fact, our observation (Table 1)
indicates that the T4-induced rise in plasma phos-
phate is more pronounced in PTX than it is in intact
animals, suggesting that the presence of PTH would
tend to attenuate the stimulatory action ofT4 on the
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tubular phosphate reabsorptive capacity. The
mechanism whereby T4 promotes a change in the
renal handling of phosphate in PTX rats does not
seem to be related to an alteration in the adenyl cy-
clase system. Indeed, in our experiments, UCAMPV/
ml GF was not diminished in hyperthyroid-PTX
rats. The significant increase in UCAMPV!ml GF ob-
served in response to phosphate infusion in both
EU and HT-PTX groups is in agreement with a re-
cent finding obtained by Webb et al. [34] in thyro-
parathyroidectomized rats. From our present ex-
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Fig. 3. Influence of hyperthyroidism on the natriuretic and diuretic response to isotonic saline infusion. The fractional (panels A and C)
and absolute (panels B and D) amount of sodium and water excreted is plotted as a function of the cumulative sodium and water load
infused during the acute administration of a 0.15 M sodium chloride solution. Hyperthyroidism appears to alter the fractional but not the
absolute amount of sodium and water excreted. Asterisks (C) denote P <0.05. Values are means SEM. See text and Table 3 for further
details.
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periment, however, it is difficult to conclude that
the rise in UCAMPV/ml GF results merely from the
elevation in plasma phosphate, since the animals
were simultaneously submitted to progressive ECV
expansion. Another recent study made in thyro-
parathyroidectomized rats [171 did not reveal any
significant increase in cAMP excretion in response
to a phosphate infusion similar to that delivered in
the present work. In these former circumstances
[171, however, the rise in plasma phosphate was not
accompanied by a conspicuous increase in expan-
sion and FENa. Therefore, it would seem appropri-
ate to further assess whether ECV expansion plays
any role [35, 36] in the elevation of UCAMPV that can
be observed during phosphate infusion in PTX ani-
mals.
Among other factors known to influence the renal
handling of phosphate, a change in the intake (118,
191 or intestinal absorption of phosphate is probably
not implied in view of the results of the balance
study. The absolute need for phosphate as deter-
mined by growth, anabolism, and bone mineral-
ization may influence the renal handling of phos-
phate. A previous study [37] showed that HT-PTX
animals have an equal rate of longitudinal growth
but a diminished rate of weight gain, compared to
pair-fed EU-PTX counterparts. No impairment in
the mineralization [37] and ash content (Bommer
and Ritz, unpublished data) of bone could be detect-
ed in the HT-PTX rats. If, in view of the reduced
weight gain, however, the need for phosphate
would be diminished in hyperthyroidism, one would
expect a decrease rather than an increase in the
tubular reabsorption of phosphate. Therefore, in
this respect only, a relative increase in the phos-
phate need of the organism could explain the tubu-
lar phosphate response to thyroxine. Whether the
influence of T4 on cellular metabolism would in-
crease phosphate requirement and thus lead sec-
ondarily to a tubular adaptation remains purely
speculative.
A previous study [381 has documented a reduc-
tion in the ECV in rats with T4-induced hyper-
thyroidism. In the present work the reduced FENa
observed in HT-PTX animals does not seem to be
the consequence of a possible reduction in ECV.
Indeed the difference in FENa between EU and HT-
FIX rats cannot be cancelled out by infusing large
amounts of isotonic saline solution (Fig. 3). Instead
of reflecting the response to a reduced ECV, the de-
crease in FENa may be interpreted as the con-
sequence of a tubular adjustment to the increased
filtered load of sodium [391. Alternatively, it could
be the results of a direct action of T4 on the tubular
reabsorption of sodium. Thyroid hormones have
been shown to influence the renal Na-K-ATPase
[40], a phenomenon which has been shown to be
associated with parallel changes in the tubular reab-
sorption of sodium (125, 39, 411. By whichever
mechanism FENa is reduced, the question arises
whether influence of T4 on phosphate reabsorption
is secondary to its action on the tubular sodium
transport. Under many circumstances, tubular
changes of the phosphate transport parallel that of
sodium [42, 431. Recently, studies on brush border
vesicles [44] support the concept of a sodium de-
pendence of phosphate transport, at least at the lev-
el of the luminal plasma membrane of the proximal
tubule. From our experiments, we cannot rule out
the possibility that the T4-induced change in the re-
nal handling of phosphate was secondary to the
stimulation of the tubular sodium transport. Indeed,
both the sodium and phosphate alterations were
maintained during marked ECV expansion (Figs, 2
and 3, Table 2). The change in the renal handling of
phosphate, however, was associated with an in-
crease in the phosphatemia. Therefore, the rise in
the tubular capacity to reabsorb phosphate cannot
be considered merely as an adaptive mechanism
tending to compensate for the augmentation in the
filtered load of phosphate caused by the increased
GFR. We cannot, however, rule out entirely the
possibility that the increased GFR in itself may
through some unknown mechanism enhance the
process of net phosphate reabsorption beyond the
rate which is needed to compensate for the increase
in filtered load. Presently, no evidence has been re-
ported which would support that GFR itself might
have such an effect on the tubular phosphate trans-
port system. Further experiments should be aimed
at ascertaining whether the parathyroid-independ-
ent action of thyroxine on the renal handling of
phosphate can be dissociated from its effect on GFR
and the tubular sodium transport. Its site of action
along the nephron should be localized and the nature
of its effect characterized. This may be accom-
plished by experiments that could answer the ques-
tion of whether thyroxine affects the net phosphate
reabsorption by altering the transport system bound
to the luminal or contraluminal membrane [44] or by
modifying the driving forces influencing this sys-
tem. Yet another possibility would be that thyrox-
ine is changing the paracellular permeability of the
tubular epithelium. Finally, the consideration that
vitamin D3 or one of its metabolites may play a me-
diating role in the action of thyroxine on the renal
Thyroxine and renal handling of phosphate 333
transport of phosphate should be included also in
future investigations.
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